Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 49 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2007Optimising reproductive and child health outcomes by building evidence-based research and practice in South East Asia (SEA-ORCHID): study protocolHenderson-Smart, D.; Lumbiganon, P.; Festin, M.; Ho, J.; Mohammad, H.; McDonald, S.; Green, S.; Crowther, C.
2007Costs and consequences of treatment for mild gestational diabetes mellitus - evaluation from the ACHOIS randomised trialMoss, J.; Crowther, C.; Hiller, J.; Willson, K.; Robinson, J.
2005Should we deliver twins electively at 37 weeks' gestation?Dodd, J.; Crowther, C.
2015Growth trajectories in early childhood, their relationship with antenatal and postnatal factors, and development of obesity by age 9 years: results from an Australian birth cohort studyGiles, L.; Whitrow, M.; Davies, M.; Davies, C.; Rumbold, A.; Moore, V.
2006Reducing multiple pregnancy from assisted reproduction treatment: educating patients and medical staffWang, J.; Lane, M.; Norman, R.
2013Magnesium sulphate for the prevention of cerebral palsy in Australia and New ZealandBain, E.; Goodchild, L.; Lontis, R.; McIntyre, S.; Ashwood, P.; Bubner, T.; Middleton, P.; Crowther, C.
2001Provider attitudes about gaining consent for perinatal autopsyKhong, T.; Turnbull, D.; Staples, A.
1995The origins of cerebral palsy - A consensus statementMacLennan, A.; Stanley, F.; Blair, E.; Rice, G.; Stone, P.; Robinson, J.; Henderson-Smart, D.; Yu, V.; Harbord, M.; Stern, L.; Chambers, H.; Furness, M.; Hayward, T.; Eckert, K.; Boundy, C.; Merrett, S.; Kenny, M.
2023Predictors of compliance with higher dose omega-3 fatty acid supplementation during pregnancy and implications for the risk of prematurity: exploratory analysis of the ORIP randomised trialSullivan, T.R.; Yelland, L.N.; Gibson, R.A.; Thakkar, S.K.; Huang, F.; Best, K.P.; Devaraj, S.; Zolezzi, I.S.; Makrides, M.
2023To guide future practice, perinatal trials should be much larger, simpler and less fragile with close to 100% ascertainment of mortality and other key outcomesTarnow-Mordi, W.O.; Robledo, K.; Marschner, I.; Seidler, L.; Simes, J.; Rieger, I.; Osborn, D.; Popat, H.; Reid, S.; de Waal, K.; Wright, I.; Wright, A.; Buchan, J.; Stubbs, M.; Newnham, J.; Simmer, K.; Young, C.; Loh, D.; Kok, Y.; Gill, A.; et al.